NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 52 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $133,000 | -54.5% | 248,888 | -42.4% | 0.00% | – |
| Q2 2020 | $292,000 | -21.9% | 432,332 | -33.5% | 0.00% | – |
| Q1 2020 | $374,000 | -64.3% | 650,112 | -18.2% | 0.00% | – |
| Q4 2019 | $1,049,000 | -45.5% | 794,981 | -17.4% | 0.00% | -100.0% |
| Q3 2019 | $1,925,000 | -18.1% | 962,429 | -0.5% | 0.00% | 0.0% |
| Q2 2019 | $2,349,000 | +26.8% | 966,829 | +27.3% | 0.00% | 0.0% |
| Q1 2019 | $1,853,000 | +111.3% | 759,245 | +26.5% | 0.00% | – |
| Q4 2018 | $877,000 | -45.9% | 600,393 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $1,621,000 | +35.4% | 600,393 | +74.5% | 0.00% | – |
| Q2 2018 | $1,197,000 | +112.6% | 344,061 | +207.6% | 0.00% | – |
| Q1 2018 | $563,000 | +129.8% | 111,865 | +173.2% | 0.00% | – |
| Q4 2017 | $245,000 | – | 40,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 4,256,526 | $11,493,000 | 2.10% |
| Vivo Capital, LLC | 6,619,190 | $17,872,000 | 1.80% |
| Novo Holdings A/S | 4,703,720 | $12,700,000 | 1.01% |
| Rock Springs Capital Management LP | 1,800,000 | $4,860,000 | 0.18% |
| Orbimed Advisors | 4,644,600 | $12,540,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 212,500 | $443,000 | 0.09% |
| Granahan Investment Management | 247,276 | $668,000 | 0.04% |
| WEDBUSH SECURITIES INC | 92,050 | $249,000 | 0.03% |
| Laurion Capital Management LP | 419,670 | $1,133,000 | 0.01% |
| SECTORAL ASSET MANAGEMENT INC | 38,255 | $103,000 | 0.01% |